Evidence map›Paper›PMID 32293342›Full record

ArticleBMC cancer2020

Unexpected response to palliative radiotherapy for subcutaneous metastases of an advanced small cell pancreatic neuroendocrine carcinoma: a case report of two different radiation schedules.

Maria Paola Ciliberti, Roberta Carbonara, Antonietta Grillo, Anna Maria Leo, Ivan Lolli, Carmela Ostuni, Laura Troiani, Barbara Turi, Simona Vallarelli, Angela Sardaro

Open access · goldAbstract readCase Reports
In one paragraph

Article in BMC cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.3field-weighted citation impact, top 41% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 2 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Maria Paola CilibertiRadiation Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico, P.zza Giulio Cesare nr.11, 70124, Bari, Italy.
Roberta CarbonaraInterdisciplinary Department of Medicine, Section of Radiology and Radiation Oncology, University of Bari "Aldo Moro", P.zza Giulio Cesare nr.11, 70124, Bari, Italy. roberta.carbonara@yahoo.it.ORCID https://orcid.org/0000-0002-4087-3063
Antonietta GrilloRadiation Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico, P.zza Giulio Cesare nr.11, 70124, Bari, Italy.
Anna Maria LeoRadiation Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico, P.zza Giulio Cesare nr.11, 70124, Bari, Italy.
Ivan LolliDepartment of Oncology, National Institute of Gastroenterology "Saverio De Bellis", Research Hospital, Via Turi, 27 Castellana Grotte, Bari, Italy.
Carmela OstuniDepartment of Oncology, National Institute of Gastroenterology "Saverio De Bellis", Research Hospital, Via Turi, 27 Castellana Grotte, Bari, Italy.
Laura TroianiDepartment of Oncology, National Institute of Gastroenterology "Saverio De Bellis", Research Hospital, Via Turi, 27 Castellana Grotte, Bari, Italy.
Barbara TuriRadiation Oncology Unit, Azienda Ospedaliero-Universitaria Policlinico, P.zza Giulio Cesare nr.11, 70124, Bari, Italy.
Simona VallarelliDepartment of Oncology, National Institute of Gastroenterology "Saverio De Bellis", Research Hospital, Via Turi, 27 Castellana Grotte, Bari, Italy.
Angela SardaroInterdisciplinary Department of Medicine, Section of Radiology and Radiation Oncology, University of Bari "Aldo Moro", P.zza Giulio Cesare nr.11, 70124, Bari, Italy.
Gastroenterology Hospital "Saverio de Bellis" · ITOspedale Pediatrico Giovanni XXIII · ITUniversity of Bari Aldo Moro · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSkin metastases from pancreatic neuroendocrine carcinoma (PNEC) are rare and their palliative treatment is challenging. We report our experience in the multimodal management of one of the few reported cases of metastatic PNEC with multiple visceral and subcutaneous secondary lesions, focusing on the effectiveness of palliative radiotherapy for skin metastases. CASE PRESENTATION: A 61-years old woman affected by a metastatic PNEC - with subcutaneous growing and bleeding secondary lesions (at the scalp, right scapular region and at the back of the left thoracic wall, respectively) - obtained a successful control of visceral metastases with the use of chemotherapy and an unexpected local response of her skin metastases with palliative radiotherapy. In particular, two subsequent radiation treatments were performed using different fractionation schedules (30 Gy in 10 fractions and 20 Gy in 5 fractions, respectively). Both radiation treatments were well-tolerated and patient's quality of life was improved. Local response was maintained until patient's death - that occurred due to cachexia.

conclusionsThe presented case highlights the effectiveness and the good tolerance of radiotherapy in the treatment of subcutaneous metastases; nevertheless, further knowledge of the optimal local palliative approach for PNEC metastatic sites is necessary. The experience gained in this work is the occasion to encourage a routine integrated multidisciplinary team management of metastatic PNECs because of their clinical complexity. The aim is to guarantee the optimization of the care with personalized and more effective systemic and local treatments - also including supportive cares and treatment-related side effects management.

Indexed as

CachexiaCarcinoma, NeuroendocrineCarcinoma, Small CellDose Fractionation, RadiationFatal OutcomeFemaleHumansMiddle AgedPalliative CarePancreatic NeoplasmsSkin NeoplasmsPalliative radiotherapyPancreatic neuroendocrine carcinomaSubcutaneous metastases

Identifiers

PMID32293342
PMCPMC7161181
OpenAlexW3015483345

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.